Study details
Enrolling now
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Vanderbilt University Medical Center
NCT IDNCT06852950ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 11 months
Ages
18+
Locations
1 site in TN
About this study
This trial is testing whether continuous glucose monitoring (CGM) helps people with diabetes manage their blood sugar levels better after they leave the hospital. The goal is to improve how well people understand and use CGM devices, as well as increase satisfaction with their overall diabetes care.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Dexcom G7 Continuous Glucose Monitor
- 2.Use Libre 3 Plus Continuous Glucose Monitor
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Degree of Average Change in Hemoglobin A1C from Start to End of Study
Devices
monitoring
Body systems
Endocrinology